Browse > Article
http://dx.doi.org/10.4014/jmb.2112.12044

CircCOL1A2 Sponges MiR-1286 to Promote Cell Invasion and Migration of Gastric Cancer by Elevating Expression of USP10 to Downregulate RFC2 Ubiquitination Level  

Li, Hang (Gastroenterology and Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University)
Chai, Lixin (Gastroenterology and Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University)
Ding, Zujun (Gastroenterology and Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University)
He, Huabo (Gastroenterology and Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University)
Publication Information
Journal of Microbiology and Biotechnology / v.32, no.7, 2022 , pp. 938-948 More about this Journal
Abstract
Gastric cancers (GC) are generally malignant tumors, occurring with high incidence and threatening public health around the world. Circular RNAs (circRNAs) play crucial roles in modulating various cancers, including GC. However, the functions of circRNAs and their regulatory mechanism in colorectal cancer (CRC) remain largely unknown. This study focuses on both the role of circCOL1A2 in CRC progression as well as its downstream molecular mechanism. Quantitative polymerase chain reaction (qPCR) and western blot were adopted for gene expression analysis. Functional experiments were performed to study the biological functions. Fluorescence in situ hybridization (FISH) and subcellular fraction assays were employed to detect the subcellular distribution. Luciferase reporter, RNA-binding protein immunoprecipitation (RIP), co-immunoprecipitation (Co-IP), RNA pull-down, and immunofluorescence (IF) and immunoprecipitation (IP) assays were used to explore the underlying mechanisms. Our results found circCOL1A2 to be not only upregulated in GC cells, but that it also propels the migration and invasion of GC cells. CircCOL1A2 functions as a competing endogenous RNA (ceRNA) by sequestering microRNA-1286 (miR-1286) to modulate ubiquitin-specific peptidase 10 (USP10), which in turn spurs the migration and invasion of GC cells by regulating RFC2. In sum, CircCOL1A2 sponges miR-1286 to promote cell invasion and migration of GC by elevating the expression of USP10 to downregulate the level of RFC2 ubiquitination. Our study offers a potential novel target for the early diagnosis and treatment of GC.
Keywords
Gastric cancer; circCOL1A2; miR-1286; USP10; RFC2;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Niu Y, Zhang J, Tong Y, Li J, Liu B. 2019. Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer. Life Sci. 237: 116893.
2 Lordick F, Hoffmeister A. 2014. [Treatment of gastric cancer]. Der Internist 55: 15-16, 18-22.   DOI
3 Xia Y, Lv J, Jiang T, Li B, Li Y, He Z, et al. 2021. CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization. J. Exp. Clin. Cancer Res. CR. 40: 103.
4 Sun J, Li T, Zhao Y, Huang L, Sun H, Wu H, et al. 2018. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN. Mol. Cell. Bochem. 441: 1-7.   DOI
5 Ko A, Han SY, Choi CH, Cho H, Lee MS, Kim SY, et al. 2018. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF. Cell Death Differ. 25: 1050-1062.   DOI
6 Zeng Z, Wu HX, Zhan N, Huang YB, Wang ZS, Yang GF, et al. 2014. Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma. Tumour Biol. 35: 3845-3853.   DOI
7 Li Y, Gan S, Ren L, Yuan L, Liu J, Wang W, et al. 2018. Multifaceted regulation and functions of replication factor C family in human cancers. Am. J. Cancer Res. 8: 1343-1355.
8 Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, et al. 2020. USP10 Promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP/TAZ. Cancer Res. 80: 2204-2216.
9 Ouyang SW, Liu TT, Liu XS, Zhu FX, Zhu FM, Liu XN, et al. 2019. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer. FEBS Lett. 593: 406-413.   DOI
10 Hu T, Shen H, Li J, Yang P, Gu Q, Fu Z. 2020. RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells. J. Cell. Physiol. 235: 8319-8333.   DOI
11 Ji Z, Li J, Wang J. 2021. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma. Hereditas 158: 17.
12 Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. 2021. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat. Commun. 12: 295.
13 Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. 2020. Gastric cancer. Lancet (London, England) 396: 635-648.   DOI
14 Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. 2014. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol. Biomarkers Prev. 23: 700-713.   DOI
15 Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, et al. 2019. Recent advances in gastric cancer early diagnosis. World J. Gastroenterol. 25: 2029-2044.   DOI
16 Ao R, Guan L, Wang Y, Wang JN. 2018. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway. J. Cell. Biochem. 119: 4420-4434.   DOI
17 Cao J, Zhang X, Xu P, Wang H, Wang S, Zhang L, et al. 2021. Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway. J. Exp. Clin. Cancer Res. 40: 6.
18 Dai X, Liu J, Guo X, Cheng A, Deng X, Guo L, et al. 2020. Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/β-catenin signalling pathway. Clin. Sci. London 134: 1821-1839.   DOI
19 Rong L, Huang W, Tian S, Chi X, Zhao P, Liu F. 2018. COL1A2 is a novel biomarker to improve clinical prediction in human gastric cancer: Integrating bioinformatics and meta-analysis. Pathol. Oncol. Res. 24: 129-134.   DOI
20 Tao Z, Shi A, Li R, Wang Y, Wang X, Zhao J. 2017. Microarray bioinformatics in cancer- a review. J. BUON 22: 838-843.
21 Zhang Y, Jiang J, Zhang J, Shen H, Wang M, Guo Z, et al. 2021. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol. Cancer 20: 101.
22 Chen Y, Li H, Ding T, Li J, Zhang Y, Wang J, et al. 2020. Lnc-M2 controls M2 macrophage differentiation via the PKA/CREB pathway. Mol. Immunol. 124: 142-152.   DOI
23 Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, et al. 2019. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Mol. Cancer 18: 167.
24 Wang LQ, Zheng YY, Zhou HJ, Zhang XX, Wu P, Zhu SM. 2021. LncRNA-Fendrr protects against the ubiquitination and degradation of NLRC4 protein through HERC2 to regulate the pyroptosis of microglia. Mol. Med. 27: 39.
25 Qu J, Yang J, Chen M, Wei R, Tian J. 2020. CircFLNA acts as a sponge of miR-646 to facilitate the proliferation, metastasis, glycolysis, and apoptosis inhibition of gastric cancer by targeting PFKFB2. Cancer Manag. Res. 12: 8093-8103.   DOI
26 Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S, et al. 2019. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene 38: 2627-2644.   DOI
27 Lee SW, Park DY, Kim MY, Kang C. 2019. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility. Gastric Cancer 22: 640-644.   DOI
28 Wei T, Ye P, Yu GY, Zhang ZY. 2020. Circular RNA expression profiling identifies specific circular RNAs in tongue squamous cell carcinoma. Mol. Med. Rep. 21: 1727-1738.
29 Hong M, Tao S, Zhang L, Diao LT, Huang X, Huang S, et al. 2020. RNA sequencing: new technologies and applications in cancer research. J. Hematol. Oncol. 13: 166.
30 Yuan S, Si W, Zhuang K, Li Y, Zhang Y, Liu J, et al. 2021. LncRNA UCID Promotes hepatocellular carcinoma metastasis via stabilization of snail. OncoTargets Ther. 14: 725-736.   DOI
31 Wang Z, Wang Z, Li G, Wu H, Sun K, Chen J, et al. 2017. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling. Cancer Lett. 385: 28-38.   DOI
32 Gou WF, Shen DF, Yang XF, Zhao S, Liu YP, Sun HZ, et al. 2015. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. Oncotarget 6: 19552-19579.   DOI
33 Liu X, Chu KM. 2017. α-Actinin-4 promotes metastasis in gastric cancer. Lab. Invest. 97: 1084-1094.   DOI
34 Cheng LL, Itahana Y, Lei ZD, Chia NY, Wu Y, Yu Y, et al. 2012. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin. Cancer Res. 18: 4201-4212.   DOI